NOBIVAC RABIES
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
29-09-2015
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
RABIES VIRUS STRAIN PASTEUR RIV INACTIVATED
थमां उपलब्ध:
Intervet Ireland Limited
ए.टी.सी कोड:
QI07AA02
INN (इंटरनेशनल नाम):
RABIES VIRUS STRAIN PASTEUR RIV INACTIVATED
डोज़:
Unknown
फार्मास्यूटिकल फॉर्म:
Suspension for Injection
प्रिस्क्रिप्शन प्रकार:
POM
चिकित्सीय समूह:
Canine, Feline
चिकित्सीय क्षेत्र:
Rabies virus vaccine
चिकित्सीय संकेत:
Immunological - Inactivated vaccine
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
2004-08-10
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobivac Rabies
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Per 1 ml dose:
ACTIVE SUBSTANCE:
Inactivated rabies virus strain Pasteur RIV inducing at least 2 IU as measured in the potency test.
ADJUVANT:
Aluminium phosphate
0.15 ml
EXCIPIENTS:
Thiomersal (preservative)
0.10 mg
For the full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of dogs and cats to reduce mortality and clinical signs of rabies.
Onset of immunity
Protective levels of circulating antibody are seen in all species within 30 days of vaccination.
Duration of immunity
Studies indicate a minimum duration of protection in dogs and cats of 3 years.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system.
Immunogenicity of the vaccine antigen will be reduced by poor storage or inappropriate administration.
Immunocompetence of the animal may be compromised by a variety of factors including poor health, nutritional status,
genetic factors, concurrent drug therapy and stress.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 14/09/2015_
_CRN 7021069_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Only healthy animals should be vaccinated. The vaccine may not be effective in animals incubating the disease at the
time of vaccination.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL P
पूरा दस्तावेज़ पढ़ें
